Affordable Access

Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly.

Authors
Type
Published Article
Journal
Clinical endocrinology
Publication Date
Volume
64
Issue
2
Pages
209–214
Identifiers
PMID: 16430722
Source
Medline
License
Unknown

Abstract

This 3-year study shows that lanreotide Autogel is effective in controlling GH/IGF-1 hypersecretion and is well tolerated during long-term treatment of patients with acromegaly.

Statistics

Seen <100 times